Automated, miniaturized and accelerated drug discovery: AMADEUS

AMADEUS is an automated platform for rapid, sustainable drug discovery that synthesizes thousands of small molecules daily, optimizing processes through AI to reduce costs and enhance accessibility.

Subsidie
€ 3.409.401
2024

Projectdetails

The mantra ‘Automation + Miniaturization = Acceleration’ is successfully applied in many research areas and technologies, but not in synthetic chemistry, which is largely believed to be not automatable.

Background

However, with the potential to accelerate discoveries while flattening costs, increasing safety, streamlining data generation, enhancing reproducibility, and lowering the environmental footprint, automation and miniaturization are two promising approaches to synthesis and are worthwhile to invest in.

Project Overview

I will engineer and validate a comprehensive technology platform, AMADEUS (Automated, MiniAturizeD, and acceleratEd drUg diScovery), which is able to synthesize in a fully autonomous manner thousands of small molecules per day in nano- or picolitre volumes, based on hundreds of chemistries, efficiently screened and optimized for properties using artificial intelligence.

Technical Details

The AMADEUS process will be achieved by interfacing four different modules:

  1. A synthetic part based on acoustic droplet ejection technology
  2. A UPLC MS QC and purification module
  3. A flexible mounted screening unit
  4. A machine learning module that retrieves and processes all relevant synthesis, QC, and screening ‘real-time’ data and automatically guides the iterative optimization cycle.

Applications

AMADEUS will be showcased with several medicinal chemistry, catalysis, and organic chemistry projects.

Challenge to Traditional Processes

With my project, I want to challenge the early drug discovery process, which for over 50 years in pharma companies around the world has (almost uniformly) been pursued and comprises two blocks:

  1. A high throughput screen relying on millions of curated and stored compounds
  2. The subsequent hit-to-lead optimization phase often called the ‘design, make, test cycle’.

Impact

AMADEUS will contribute to the accelerated discovery of drugs for unmet medical needs and ultimately reduce drug costs for patients.

Sustainability

AMADEUS is a highly sustainable synthesis platform.

Democratization of Drug Discovery

AMADEUS will help democratize drug discovery.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.409.401
Totale projectbegroting€ 3.409.401

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERZITA PALACKEHO V OLOMOUCIpenvoerder

Land(en)

Czechia

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC POC

High-throughput combinatory drugs testing on in vitro 3D cells model platform

The project aims to develop a microfluidic platform for high-throughput screening of drug combinations in 3D cultures to enhance drug discovery and identify synergistic therapies for breast cancer.

€ 150.000
ERC STG

Scalable Microbial Metabolite Discovery Through Synthetic Biology

This project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development.

€ 1.490.250
EIC Pathfinder

Personalised Adaptive Medicine

The PERAMEDIC project aims to develop a desktop-sized system for personalized polypill formulation using 3D printing and precise dosing to enhance treatment outcomes and patient adherence.

€ 1.726.876
ERC POC

High throughput development platform for oligonucleotide aptamers

SPARXS is an innovative platform that enables rapid design of affinity probes by simultaneously analyzing binding kinetics and sequences of millions of aptamers for diverse applications.

€ 150.000